A risk marker given by 8 genes (VDR, HIP2, CLTB, FPRL2, CA12, CEACAM4, ACRV1, and UTX) predicted PD and was not biased by dopamine replacement therapy. This evidence concerns the gene FPR3 and Parkinson disease.